Immunotherapy Targeting Tumor Mutations Leads to Complete Response in Advanced Breast Cancer Patient, NIH Reports

A tweaked version of a cellular immunotherapy that recognizes mutations in a patient’s tumor has led to the complete regression of metastatic breast cancer in a woman whose disease had failed to respond to multiple lines of chemotherapy, a study reports.
https://immuno-oncologynews.com/2018/06/08/immunotherapy-targeting-tumor-mutations-leads-to-complete-response-in-breast-cancer-patient-nih-reports/